Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Nippon India ELSS Tax Saver Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹150.22 |
| 26 Aug 2009 | ₹113.36 |
| 08 May 2011 | ₹154.73 |
| 17 Jan 2013 | ₹179.54 |
| 30 Sep 2014 | ₹309.52 |
| 11 Jun 2016 | ₹330.07 |
| 21 Feb 2018 | ₹462.99 |
| 04 Nov 2019 | ₹403.56 |
| 16 Jul 2021 | ₹511.86 |
| 28 Mar 2023 | ₹551.89 |
| 08 Dec 2024 | ₹951.88 |
| 20 Aug 2026 | ₹966.20 |
| Metric | Nippon India · Regular NAV ₹131.60 Very High risk ★★★☆☆ | Category median ELSS · 51 funds |
|---|---|---|
| +1.34% | +2.06% | |
| +13.69% | +13.00% | |
| +12.96% | +12.22% | |
| +10.24% | +12.69% | |
| +11.77% | +13.09% | |
| +11.76% | — | |
| +13.99% | +14.73% | |
| +13.44% | +15.15% | |
| +13.12% | +14.10% | |
| Risk | ||
| 14.47% | 14.18% | |
| 0.50 | 0.47 | |
| 0.67 | 0.63 | |
| -60.01% | -37.97% | |
| Nifty 500 | — | |
| +1.53% | +0.84% | |
| 0.96 | 0.97 | |
| 102.0% | 100.1% | |
| 94.3% | 95.6% | |
| 1.78% | 1.93% | |
| ₹14,662Cr | ₹857.48Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹2.02K | — | |
| 50% | 33% | |
| Kinjal Desai | — | |
| 03 Apr 2006 | — | |
| 64 | — | |
| 39.4% | — | |
| 1.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.